Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection TestsTiago Brito‐Rocha, Cármen Jerónimo|Cells|2023Cited by 95
Epigenetic modulators as therapeutic targets in prostate cancerInês Graça, Cármen Jerónimo|Clinical Epigenetics|2016Cited by 90
Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancerDiogo Almeida-Rios, Cármen Jerónimo|Oncotarget|2016Cited by 67
External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter CohortLi-Mei Chen, Charles J. Rosser, Yunfeng Dai et al.|Cancer Epidemiology Biomarkers & Prevention|2014Cited by 65
Anti-neoplastic properties of hydralazine in prostate cancerInês Graça, Cármen Jerónimo|Oncotarget|2014Cited by 63